|
DK2903968T3
(en)
|
2012-10-02 |
2017-01-30 |
Gilead Sciences Inc |
INHIBITORS OF HISTON DEMETHYLASES
|
|
SG11201504946VA
(en)
|
2012-12-21 |
2015-07-30 |
Quanticel Pharmaceuticals Inc |
Histone demethylase inhibitors
|
|
EP2935303B1
(en)
|
2012-12-21 |
2021-02-17 |
Janssen BioPharma, Inc. |
4'-fluoro-nucleosides, 4'-fluoro-nucleotides and analogs thereof for the treatment of hcv
|
|
EA030451B1
(ru)
|
2013-02-27 |
2018-08-31 |
Эпитерапьютикс Апс |
Ингибиторы гистондеметилаз
|
|
JO3509B1
(ar)
|
2013-03-14 |
2020-07-05 |
Janssen Pharmaceutica Nv |
معدلات p2x7
|
|
JO3773B1
(ar)
|
2013-03-14 |
2021-01-31 |
Janssen Pharmaceutica Nv |
معدلات p2x7
|
|
WO2014140075A1
(en)
|
2013-03-14 |
2014-09-18 |
Boehringer Ingelheim International Gmbh |
Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
|
|
JP6467404B2
(ja)
|
2013-03-14 |
2019-02-13 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｐ２ｘ７モジュレーター
|
|
EP3112366B1
(en)
|
2013-03-14 |
2018-02-28 |
Janssen Pharmaceutica NV |
P2x7 modulators
|
|
JP6783224B2
(ja)
|
2014-04-04 |
2020-11-11 |
デル マー ファーマシューティカルズ |
肺の非小細胞癌腫及び卵巣癌を処置するためのジアンヒドロガラクチトール及びその類縁体又は誘導体の使用
|
|
PL3160952T3
(pl)
*
|
2014-06-25 |
2021-07-19 |
Celgene Quanticel Research, Inc. |
Inhibitory metylazy histonowej
|
|
BR112017003442A2
(pt)
|
2014-08-27 |
2017-11-28 |
Gilead Sciences Inc |
compostos e métodos para inibir histona desmetilases
|
|
JP6592510B2
(ja)
|
2014-09-12 |
2019-10-16 |
ヤンセン ファーマシューティカ エヌ．ベー． |
Ｐ２ｘ７調節因子
|
|
CA2960972C
(en)
|
2014-09-12 |
2023-10-03 |
Janssen Pharmaceutica Nv |
P2x7 modulating n-acyl-triazolopyrazines
|
|
JP2017526716A
(ja)
|
2014-09-12 |
2017-09-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
カテプシンｃのスピロ環状阻害剤
|
|
US10030017B2
(en)
|
2014-09-17 |
2018-07-24 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
AU2015317806A1
(en)
|
2014-09-17 |
2017-04-13 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
CN108698997A
(zh)
*
|
2015-12-28 |
2018-10-23 |
赛尔基因昆蒂赛尔研究公司 |
组蛋白脱甲基酶抑制剂
|
|
ES2921009T3
(es)
*
|
2016-03-15 |
2022-08-16 |
Celgene Quanticel Res Inc |
Inhibidores de desmetilasas de histonas
|
|
KR101725292B1
(ko)
|
2016-03-30 |
2017-04-10 |
한국과학기술연구원 |
항암 활성을 갖는 신규 피리미딘-4-카르복시산 유도체
|
|
US10150754B2
(en)
|
2016-04-19 |
2018-12-11 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
WO2017198785A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Ieo - Istituto Europeo Di Oncologia S.R.L. |
Oxime derivatives useful as inhibitors of histone demethylase kdm4c
|
|
BR102017010009A2
(pt)
|
2016-05-27 |
2017-12-12 |
Gilead Sciences, Inc. |
Compounds for the treatment of hepatitis b virus infection
|
|
MA45088A
(fr)
|
2016-05-27 |
2019-04-10 |
Gilead Sciences Inc |
Méthodes pour traiter des infections par le virus de l'hépatite b au moyen d'inhibiteurs de ns5a, ns5b ou ns3
|
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
|
ES2906581T3
(es)
|
2016-09-02 |
2022-04-19 |
Gilead Sciences Inc |
Compuestos moduladores de los receptores tipo Toll
|
|
ES2826748T3
(es)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
|
|
SG11201903042VA
(en)
|
2016-10-14 |
2019-05-30 |
Precision Biosciences Inc |
Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
|
|
TWI820984B
(zh)
|
2017-01-31 |
2023-11-01 |
美商基利科學股份有限公司 |
替諾福韋埃拉酚胺(tenofovir alafenamide)之晶型
|
|
JOP20180008A1
(ar)
|
2017-02-02 |
2019-01-30 |
Gilead Sciences Inc |
مركبات لعلاج إصابة بعدوى فيروس الالتهاب الكبدي b
|
|
ES2991090T3
(es)
|
2017-03-30 |
2024-12-02 |
Univ Freiburg Albert Ludwigs |
Inhibidores de KDM4
|
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
|
UY37774A
(es)
*
|
2017-06-19 |
2019-01-31 |
Novartis Ag |
Compuestos 5-cianoindol sustituidos y usos de los mismos
|
|
US11203610B2
(en)
|
2017-12-20 |
2021-12-21 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
WO2019123340A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
MX2020008404A
(es)
|
2018-02-13 |
2020-09-25 |
Gilead Sciences Inc |
Inhibidores de molecula de muerte programada 1 (pd-1)/ligando de molecula de muerte programada 1 (pd-l1).
|
|
CN111788204B
(zh)
|
2018-02-26 |
2023-05-05 |
吉利德科学公司 |
作为hbv复制抑制剂的取代吡咯嗪化合物
|
|
WO2019195181A1
(en)
|
2018-04-05 |
2019-10-10 |
Gilead Sciences, Inc. |
Antibodies and fragments thereof that bind hepatitis b virus protein x
|
|
TWI833744B
(zh)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-環二核苷酸
|
|
TWI818007B
(zh)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-環二核苷酸
|
|
TW202005654A
(zh)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
２，２，─環二核苷酸
|
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
|
ES3035911T3
(en)
|
2018-04-19 |
2025-09-11 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
|
US20190359645A1
(en)
|
2018-05-03 |
2019-11-28 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides comprising carbocyclic nucleotide
|
|
SI3820572T1
(sl)
|
2018-07-13 |
2023-12-29 |
Gilead Sciences, Inc. |
Inhibitorji pd-1/pd-l1
|
|
WO2020028097A1
(en)
|
2018-08-01 |
2020-02-06 |
Gilead Sciences, Inc. |
Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid
|
|
MY205440A
(en)
|
2018-09-28 |
2024-10-21 |
Janssen Pharmaceutica Nv |
Monoacylglycerol lipase modulators
|
|
JP7413368B2
(ja)
|
2018-09-28 |
2024-01-15 |
ヤンセン ファーマシューティカ エヌ．ベー． |
モノアシルグリセロールリパーゼ調節因子
|
|
JP7158577B2
(ja)
|
2018-10-24 |
2022-10-21 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｐｄ－１／ｐｄ－ｌ１阻害剤
|
|
CN117105933A
(zh)
|
2018-10-31 |
2023-11-24 |
吉利德科学公司 |
具有hpk1抑制活性的取代的6-氮杂苯并咪唑化合物
|
|
LT3873903T
(lt)
|
2018-10-31 |
2024-05-10 |
Gilead Sciences, Inc. |
Pakeistieji 6-azabenzimidazolo junginiai, kaip hpk1 inhibitoriai
|
|
CA3129022C
(en)
|
2019-03-07 |
2023-08-01 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotides and prodrugs thereof
|
|
EP3935066A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
WO2020178768A1
(en)
|
2019-03-07 |
2020-09-10 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
TW202212339A
(zh)
|
2019-04-17 |
2022-04-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI751516B
(zh)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
類鐸受體調節劑之固體形式
|
|
TWI826690B
(zh)
|
2019-05-23 |
2023-12-21 |
美商基利科學股份有限公司 |
經取代之烯吲哚酮化物及其用途
|
|
JP7295283B2
(ja)
|
2019-06-25 |
2023-06-20 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｆｌｔ３ｌ－ｆｃ融合タンパク質及び使用方法
|
|
WO2021011891A1
(en)
|
2019-07-18 |
2021-01-21 |
Gilead Sciences, Inc. |
Long-acting formulations of tenofovir alafenamide
|
|
WO2021034804A1
(en)
|
2019-08-19 |
2021-02-25 |
Gilead Sciences, Inc. |
Pharmaceutical formulations of tenofovir alafenamide
|
|
CR20220129A
(es)
|
2019-09-30 |
2022-05-06 |
Gilead Sciences Inc |
Vacunas para vhb y métodos de tratamiento de vhb
|
|
CA3156100A1
(en)
|
2019-09-30 |
2021-04-08 |
Janssen Pharmaceutica Nv |
Radiolabelled mgl pet ligands
|
|
EP4069729B1
(en)
|
2019-12-06 |
2025-01-22 |
Precision BioSciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome
|
|
TW202421168A
(zh)
|
2020-03-20 |
2024-06-01 |
美商基利科學股份有限公司 |
4’-c-經取代-2-鹵基-2’-去氧腺苷核苷之前藥及其製造與使用方法
|
|
MX2022011902A
(es)
|
2020-03-26 |
2023-01-04 |
Janssen Pharmaceutica Nv |
Moduladores de la monoacilglicerol lipasa.
|
|
CN116194144A
(zh)
|
2020-08-07 |
2023-05-30 |
吉利德科学公司 |
膦酰胺核苷酸类似物的前药及其药物用途
|
|
TW202406932A
(zh)
|
2020-10-22 |
2024-02-16 |
美商基利科學股份有限公司 |
介白素2-Fc融合蛋白及使用方法
|
|
AU2022274607A1
(en)
|
2021-05-13 |
2023-11-16 |
Gilead Sciences, Inc. |
COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
|
|
AU2022299051B2
(en)
|
2021-06-23 |
2025-03-13 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
US11932634B2
(en)
|
2021-06-23 |
2024-03-19 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
US11999733B2
(en)
|
2021-06-23 |
2024-06-04 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
US11926628B2
(en)
|
2021-06-23 |
2024-03-12 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
CN114907318B
(zh)
*
|
2022-07-04 |
2023-08-11 |
郑州大学 |
一种异烟酸-吡唑衍生物及其制备方法和应用
|
|
WO2025021217A1
(en)
*
|
2023-07-27 |
2025-01-30 |
Beigene Switzerland Gmbh |
Quinoline derivatives and pharmarceutical compositions thereof for the treatment of disease
|
|
WO2025240243A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with bulevirtide and an inhibitory nucleic acid targeting hepatitis b virus
|
|
US20250345390A1
(en)
|
2024-05-13 |
2025-11-13 |
Gilead Sciences, Inc. |
Combination therapies
|
|
WO2025240242A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with ribavirin
|
|
WO2025240246A1
(en)
|
2024-05-13 |
2025-11-20 |
Gilead Sciences, Inc. |
Combination therapies with ribavirin
|